Name: Senti Biosciences, Inc. (SNTI) Financial Statements
Creator: FinSpry

Senti Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Senti Biosciences, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	2.56	3.29	2.76	0.57
Cost of Revenue	0.00	32.15	28.15	21.96	15.96
Gross Profit	0.00	-29.59	4.29	-19.20	-15.39
Operating Expenses
Research & Development	34.36	32.15	28.15	21.96	0.00
Selling, General & Administrative	23.51	34.85	37.63	21.25	9.30
Operating Expenses	60.73	34.85	65.37	21.25	9.30
Operating Income	-60.73	-64.44	-62.08	-40.45	-24.69
Other Income/Expense
Interest Income	0.95	2.86	1.70	0.01	0.09
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	6.99	3.30	10.72	-0.12	-0.05
Income
Income Before Tax	-52.79	-83.41	-49.67	-55.32	-19.86
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-52.79	-71.06	-58.21	-55.32	-19.86
Net Income - Continuous Operations	-52.79	-83.41	-49.67	-55.32	0.00
Net Income - Discontinued Operations	0.00	12.35	-8.55	0.00	0.00
EBITDA	-54.88	-60.88	-58.16	-39.68	-24.13
EBIT	-60.73	-64.44	-62.08	-40.45	-24.69
Depreciation & Amortization	2.86	3.56	0.59	0.77	0.56
Earnings Per Share
Basic EPS	-12.00	-16.00	-22.00	-190.00	-14.00
Diluted EPS	-12.00	-16.00	-22.00	-190.00	-14.00
Basic Shares Outstanding	4.60	4.44	2.61	0.29	1.39
Diluted Shares Outstanding	4.60	4.44	2.61	0.29	1.39